Literature DB >> 20493174

55K isoform of CDK9 associates with Ku70 and is involved in DNA repair.

Hongbing Liu1, Christine H Herrmann, Karen Chiang, Tzu-Ling Sung, Sung-Hwan Moon, Lawrence A Donehower, Andrew P Rice.   

Abstract

Positive elongation factor b (P-TEFb) is a cellular protein kinase that is required for RNA polymerase II (RNAP II) transcriptional elongation of protein coding genes. P-TEFb is a set of different molecular complexes, each containing CDK9 as the catalytic subunit. There are two isoforms of the CDK9 protein - the major 42KDa CDK9 isoform and the minor 55KDa isoform that is translated from an in-frame mRNA that arises from an upstream transcriptional start site. We found that shRNA depletion of the 55K CDK9 protein in HeLa cells induces apoptosis and double-strand DNA breaks (DSBs). The levels of apoptosis and DSBs induced by the depletion were reduced by expression of a 55K CDK9 protein variant resistant to the shRNA, indicating that these phenotypes are the consequence of depletion of the 55K protein and not off-target effects. We also found that the 55K CDK9 protein, but not the 42K CDK9 protein, specifically associates with Ku70, a protein involved in DSB repair. Our findings suggest that the 55K CDK9 protein may function in repair of DNA through an association with Ku70. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493174      PMCID: PMC2900499          DOI: 10.1016/j.bbrc.2010.05.092

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Nucleolar proteome dynamics.

Authors:  Jens S Andersen; Yun W Lam; Anthony K L Leung; Shao-En Ong; Carol E Lyon; Angus I Lamond; Matthias Mann
Journal:  Nature       Date:  2005-01-06       Impact factor: 49.962

2.  Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines.

Authors:  C H Herrmann; R G Carroll; P Wei; K A Jones; A P Rice
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

3.  Genomic organization and characterization of promoter function of the human CDK9 gene.

Authors:  H Liu; A P Rice
Journal:  Gene       Date:  2000-07-11       Impact factor: 3.688

4.  Identification of a novel isoform of Cdk9.

Authors:  Sarah M Shore; Sarah A Byers; Wendy Maury; David H Price
Journal:  Gene       Date:  2003-03-27       Impact factor: 3.688

5.  Characterization of Cdk9(55) and differential regulation of two Cdk9 isoforms.

Authors:  Sarah M Shore; Sarah A Byers; Paul Dent; David H Price
Journal:  Gene       Date:  2005-04-25       Impact factor: 3.688

6.  Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap.

Authors:  T Mimori; M Akizuki; H Yamagata; S Inada; S Yoshida; M Homma
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

7.  Differential localization and expression of the Cdk9 42k and 55k isoforms.

Authors:  Hongbing Liu; Christine H Herrmann
Journal:  J Cell Physiol       Date:  2005-04       Impact factor: 6.384

8.  Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

Authors:  Xiao-Feng Qin; Dong Sung An; Irvin S Y Chen; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

Review 9.  Regulation of TAK/P-TEFb in CD4+ T lymphocytes and macrophages.

Authors:  Andrew P Rice; Christine H Herrmann
Journal:  Curr HIV Res       Date:  2003-10       Impact factor: 1.581

10.  A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation.

Authors:  Matjaz Barboric; B Matija Peterlin
Journal:  PLoS Biol       Date:  2005-02       Impact factor: 8.029

View more
  19 in total

1.  Penetrance of biallelic SMARCAL1 mutations is associated with environmental and genetic disturbances of gene expression.

Authors:  Alireza Baradaran-Heravi; Kyoung Sang Cho; Bas Tolhuis; Mrinmoy Sanyal; Olena Morozova; Marie Morimoto; Leah I Elizondo; Darren Bridgewater; Joanna Lubieniecka; Kimberly Beirnes; Clara Myung; Danny Leung; Hok Khim Fam; Kunho Choi; Yan Huang; Kira Y Dionis; Jonathan Zonana; Kory Keller; Peter Stenzel; Christy Mayfield; Thomas Lücke; Arend Bokenkamp; Marco A Marra; Maarten van Lohuizen; David B Lewis; Chad Shaw; Cornelius F Boerkoel
Journal:  Hum Mol Genet       Date:  2012-02-28       Impact factor: 6.150

Review 2.  A role for CDK9-cyclin K in maintaining genome integrity.

Authors:  David S Yu; David Cortez
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

3.  Cdk9 T-loop phosphorylation is regulated by the calcium signaling pathway.

Authors:  Rajesh Ramakrishnan; Andrew P Rice
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

4.  The effect of alcoholic extract from Eucalyptus camaldulensis leaves on HTLV-1 Tax activities.

Authors:  Aya Abu-Jafar; Manal Suleiman; Noa Nesim; Mahmoud Huleihel
Journal:  Cell Cycle       Date:  2020-06-21       Impact factor: 4.534

5.  Cyclin-dependent kinase 9-cyclin K functions in the replication stress response.

Authors:  David S Yu; Runxiang Zhao; Emory L Hsu; Jennifer Cayer; Fei Ye; Yan Guo; Yu Shyr; David Cortez
Journal:  EMBO Rep       Date:  2010-10-08       Impact factor: 8.807

Review 6.  Overview of CDK9 as a target in cancer research.

Authors:  Fatima Morales; Antonio Giordano
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 7.  Commuting to Work: Nucleolar Long Non-Coding RNA Control Ribosome Biogenesis from Near and Far.

Authors:  Victoria Mamontova; Barbara Trifault; Lea Boten; Kaspar Burger
Journal:  Noncoding RNA       Date:  2021-07-14

8.  Limited redundancy in genes regulated by Cyclin T2 and Cyclin T1.

Authors:  Rajesh Ramakrishnan; Wendong Yu; Andrew P Rice
Journal:  BMC Res Notes       Date:  2011-07-26

9.  Cyclin K goes with Cdk12 and Cdk13.

Authors:  Jiri Kohoutek; Dalibor Blazek
Journal:  Cell Div       Date:  2012-04-18       Impact factor: 5.130

Review 10.  CDK9 keeps RNA polymerase II on track.

Authors:  Sylvain Egloff
Journal:  Cell Mol Life Sci       Date:  2021-06-19       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.